Martin Shkreli’s Ex-Lawyer Is Convicted of Fraud
- 6 years ago
Martin Shkreli’s Ex-Lawyer Is Convicted of Fraud
The lawyer, Evan Greebel, who was outside counsel to Mr. Shkreli’s former drug company, Retrophin, was found guilty
by a jury in Brooklyn of charges he conspired to commit wire fraud and securities fraud, prosecutors said.
“We will continue to fight for justice for Evan Greebel and his family.”
A different jury found Mr. Shkreli guilty in August of defrauding hedge fund investors,
but cleared him of conspiring with Mr. Greebel to steal from Retrophin.
Martin Shkreli steal millions of dollars and cover up Shkreli’s fraud, the defendant Evan Greebel betrayed
the trust placed in him by Retrophin’s board of directors to represent the company’s best interests.”
Mr. Shkreli, 34, became notorious in 2015 when, as chief executive of Turing Pharmaceuticals,
he raised the price of the anti-parasitic drug Daraprim to $750 a pill, from $13.50.
A lawyer who once advised the former drug company executive Martin Shkreli was convicted
on Wednesday of helping Mr. Shkreli defraud a pharmaceutical company.
The charges he and Mr. Greebel faced were related to Mr. Shkreli’s management of, Retrophin
and of two hedge funds he ran, MSMB Capital and MSMB Healthcare, from 2009 to 2014.
Mr. Greebel was charged with assisting Mr. Shkreli in defrauding Retrophin through a series of settlement and sham consulting agreements.
The lawyer, Evan Greebel, who was outside counsel to Mr. Shkreli’s former drug company, Retrophin, was found guilty
by a jury in Brooklyn of charges he conspired to commit wire fraud and securities fraud, prosecutors said.
“We will continue to fight for justice for Evan Greebel and his family.”
A different jury found Mr. Shkreli guilty in August of defrauding hedge fund investors,
but cleared him of conspiring with Mr. Greebel to steal from Retrophin.
Martin Shkreli steal millions of dollars and cover up Shkreli’s fraud, the defendant Evan Greebel betrayed
the trust placed in him by Retrophin’s board of directors to represent the company’s best interests.”
Mr. Shkreli, 34, became notorious in 2015 when, as chief executive of Turing Pharmaceuticals,
he raised the price of the anti-parasitic drug Daraprim to $750 a pill, from $13.50.
A lawyer who once advised the former drug company executive Martin Shkreli was convicted
on Wednesday of helping Mr. Shkreli defraud a pharmaceutical company.
The charges he and Mr. Greebel faced were related to Mr. Shkreli’s management of, Retrophin
and of two hedge funds he ran, MSMB Capital and MSMB Healthcare, from 2009 to 2014.
Mr. Greebel was charged with assisting Mr. Shkreli in defrauding Retrophin through a series of settlement and sham consulting agreements.